Translation to human outcomes is not demonstrated
Peptides can be customized for different outcomes
GHK-Cu Standard Research Protocol Dose: 2 5 mg (= 410 clicks) Duration: 2 4 weeks Frequency: Daily Cycle Interval: 2-week pause Goal / Description: Used for baseline collagen and regeneration studies
De Groot AS, Roberts BJ, Mattei A, Lelias S, Boyle C, Martin WD
When used, monitoring of maternal vital signs and general condition can provide reassurance that no adverse reactions (like excessive hypotension from niacinamide) are occurring
Diseases such as rheumatoid arthritis, gout, or thyroid imbalance can contribute to bursitis